Ocular Therapeutix, Inc. (OCUL)
$7.56+0.27%Close
SELLCRISIS · day 11
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV45.1%–417.8%
- Market cap
- $1.7B
- Beta
- 0.97
- P/E (TTM)
- -5.17
- IV-%ile
- 77
- IV ATM
- 131.6%
- Short % float
- 15.95%
- Days to cover
- 7.3
- SI change
- -1.7%
- 1W
- +4.28%
- 1M
- -27.93%
- vs SPY 1W
- +3.85%
- vs SPY 1M
- -29.99%
Industry peers
FMP comparable companies · ranked by market cap
- GKOSBUYGlaukos Corporation$10.2BRECOVERYQ 19$172.18+1.41%
- BLCOSELLBausch + Lomb Corporation$6.2BBEARQ 1$17.34-7.11%
- KODBUYKodiak Sciences Inc.$5.7BBULLQ 42$91.08-0.61%
- HROWSELLHarrow Health, Inc.$1.1BCRISISQ 14$30.62-0.85%
- STAABUYSTAAR Surgical Company$1.1BRECOVERYQ 13$22.36+1.57%
- SGPSELLSpyGlass Pharma, Inc. Common Stock$799MQ 3$23.90-0.24%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on OCUL?
- LOPJLB’s latest quantitative signal on Ocular Therapeutix, Inc. (OCUL) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is OCUL in?
- Ocular Therapeutix, Inc. (OCUL) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Ocular Therapeutix, Inc. (OCUL) do?
- Ocular Therapeutix, Inc. is a biopharmaceutical company specializing in the creation, advancement, and commercialization of ophthalmic treatments. Their innovative approach leverages a proprietary bioresorbable hydrogel technology to address a range of eye diseases and conditions. The company currently offers two key products: ReSure Sealant, an ophthalmic device designed to prevent fluid leaka…